Press Releases
-
- Two biopharmaceutical experts join SK bioscience to strengthen the future strategies - With recru...2023.01.20
-
The world-second developed shingles vaccine ‘SKYZoster®’ is approved by the National Pharmaceutical ...2023.01.09
-
SK bioscience received A+ in Social and A in Environment and Governance categories in the first ESG ...2022.11.25
-
SK bioscience and IVI had a conference to discuss a cooperation against the next pandemic SK de...2022.11.17
-
SK bioscience explained the company’s sustainable growth strategy at investors meeting SK will...2022.11.01
-
SK bioscience, a global innovative vaccine and biotech company committed to promoting human healt...2022.10.27
-
-CEPI supports up to 40 mil. USD for early development of mRNA vaccine platform to SK bioscience; ...2022.10.25
-
- Global experts continue to join SK bioscience, while its U.S. corporate entity is being establishe...2022.10.21
-
Company submitted an application for CMA of SKYCovione™ to MHRA and EMA, followed by EUL to WHO. ...2022.09.08
-
· 609,000 doses of advance purchased SKYCovione™ will be sequentially supplied based on the vacci...2022.09.02
-
[16 August 2022] SK bioscience announced that Tae Won Chey, Chairman of SK group, Chang Won (Andr...2022.08.16
-
SK extends the vaccination age of Nuvaxovid to 12 to 17-year-oldsThe recombinant protein-based vacci...2022.08.12